Meta-analysis of C677T Genetic Polymorphism in Methylenetetra-Hydrofolate Reductase in Chinese and Acute Lymphoblastic Leukemia

LIU En-yi,HUANG Lin,ZHAO Li-bo,LIU Yi,YANG Wei,LI Yu-zhen

2012-01-01

Abstract:Objective:To investigate the relationship between methylenetetrahydrofolate reductase(MTHFR) C677T gene polymorphisms and susceptibility to acute lymphoblastic leukemia(ALL) and toxicity of methotrexate(MTX) chemotherapy.Methods:The literatures involving MTHER C677T of Chinese and ALL which calculated the pooled OR or RR were searched and reviewed,and the heterogeneity,bias and sensitivity of the results of the eligible literatures were studied by RevMan 5.0.Results:Seven studies involving MTHFR C677T gene polymorphism and ALL were enrolled,which consisted of 824 cases and 1090 cases of control.The statistical analysis result was as follows: TT+CT vs.CC: fixed effect model OR=0.76,95% CI: 0.63～0.91;random effect model OR=0.70,95% CI: 0.52～0.93,TT vs.CC+CT: fixed effect model OR=0.90,95% CI: 0.70～1.15;random effect model OR=0.93,95% CI: 0.53～1.61.The bias examined by graph of the funnel plot showed no significance.Three studies involving MTHFR C677T gene polymorphism and toxicity of MTX chemotherapy consisted of 138 cases.The statistical analysis result was as follows: TT+CT vs.CC: fixed effect model OR=0.90,95% CI: 0.70～1.15;random effect model OR=2.96,95% CI: 0.66～13.32,TT vs.CC+CT: fixed effect model OR=2.68,95% CI: 1.14～6.29;random effect model OR=3.31,95% CI: 0.57～19.21.Conclution: The mutation of MTHFR 677C→T is a protective factor of ALL development,while there is no correlation between MTHFR 677TT genotype and ALL risk.There is no correlation between MTHFR genetic polymorphism and toxicity of MTX chemotherapy.Further study with a large number of samples is needed for more reliable conclusions.